PortfoliosLab logoPortfoliosLab logo
SEIC vs. SMMT
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

SEIC vs. SMMT - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in SEI Investments Company (SEIC) and Summit Therapeutics Inc. (SMMT). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, SEIC achieves a 10.63% return, which is significantly higher than SMMT's -18.52% return. Over the past 10 years, SEIC has outperformed SMMT with an annualized return of 8.12%, while SMMT has yielded a comparatively lower 5.94% annualized return.


SEIC

1D
-0.33%
1M
0.23%
YTD
10.63%
6M
6.01%
1Y
7.75%
3Y*
18.03%
5Y*
9.45%
10Y*
8.12%

SMMT

1D
-0.21%
1M
-14.26%
YTD
-18.52%
6M
-21.36%
1Y
-30.11%
3Y*
75.20%
5Y*
17.22%
10Y*
5.94%
*Multi-year figures are annualized to reflect compound growth (CAGR)

SEIC vs. SMMT - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
SEIC
SEI Investments Company
10.63%0.63%31.47%10.59%-2.94%7.38%-11.10%43.35%-34.92%46.99%
SMMT
Summit Therapeutics Inc.
-18.52%-1.99%583.72%-38.59%57.99%-42.77%193.75%39.13%-89.62%29.44%

Correlation

The correlation between SEIC and SMMT is 0.18, which is low. Their price movements are largely independent, making them effective diversification partners.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.18

Correlation (3Y)
Calculated over the trailing 3-year period

0.21

Correlation (5Y)
Calculated over the trailing 5-year period

0.20

Correlation (10Y)
Calculated over the trailing 10-year period

0.13

Correlation (All Time)
Calculated using the full available price history since Mar 5, 2015

0.13

Fundamentals

Market Cap

SEIC:

$11.23B

SMMT:

$11.05B

EPS

SEIC:

$5.85

SMMT:

-$1.60

PB Ratio

SEIC:

4.58

SMMT:

20.24

Total Revenue (TTM)

SEIC:

$2.37B

SMMT:

$0.00

Gross Profit (TTM)

SEIC:

$925.04M

SMMT:

-$83.36K

EBITDA (TTM)

SEIC:

$928.43M

SMMT:

-$738.34M

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

SEIC vs. SMMT — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

SEIC
SEIC Risk / Return Rank: 5050
Overall Rank
SEIC Sharpe Ratio Rank: 5555
Sharpe Ratio Rank
SEIC Sortino Ratio Rank: 4848
Sortino Ratio Rank
SEIC Omega Ratio Rank: 4646
Omega Ratio Rank
SEIC Calmar Ratio Rank: 5252
Calmar Ratio Rank
SEIC Martin Ratio Rank: 5252
Martin Ratio Rank

SMMT
SMMT Risk / Return Rank: 2626
Overall Rank
SMMT Sharpe Ratio Rank: 2525
Sharpe Ratio Rank
SMMT Sortino Ratio Rank: 2929
Sortino Ratio Rank
SMMT Omega Ratio Rank: 2828
Omega Ratio Rank
SMMT Calmar Ratio Rank: 2323
Calmar Ratio Rank
SMMT Martin Ratio Rank: 2626
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

SEIC vs. SMMT - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for SEI Investments Company (SEIC) and Summit Therapeutics Inc. (SMMT). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


SEICSMMTDifference
Sharpe ratioReturn per unit of total volatility

+0.75

Sortino ratioReturn per unit of downside risk

+0.78

Omega ratioGain probability vs. loss probability

1.08

0.98

+0.09

Calmar ratioReturn relative to maximum drawdown

0.40

-0.54

+0.95

Martin ratioReturn relative to average drawdown

0.77

-0.84

+1.61

SEIC vs. SMMT - Sharpe Ratio Comparison

The current SEIC Sharpe Ratio is 0.35, which is higher than the SMMT Sharpe Ratio of -0.40. The chart below compares the historical Sharpe Ratios of SEIC and SMMT, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

SEIC vs. SMMT - Drawdown Comparison

The maximum SEIC drawdown since its inception was -71.17%, smaller than the maximum SMMT drawdown of -95.75%. Use the drawdown chart below to compare losses from any high point for SEIC and SMMT.


Loading charts...

Drawdown Indicators


SEICSMMTDifference

Max Drawdown

Largest peak-to-trough decline

-71.17%

-95.75%

+24.58%

Max Drawdown (1Y)

Largest decline over 1 year

-19.36%

-55.49%

+36.13%

Max Drawdown (3Y)

Largest decline over 3 years

-23.25%

-64.44%

+41.19%

Max Drawdown (5Y)

Largest decline over 5 years

-26.00%

-91.78%

+65.78%

Max Drawdown (10Y)

Largest decline over 10 years

-51.78%

-95.75%

+43.97%

Current Drawdown

Current decline from peak

-2.67%

-61.17%

+58.50%

Average Drawdown

Average peak-to-trough decline

-21.16%

-57.64%

+36.48%

Ulcer Index

Depth and duration of drawdowns from previous peaks

10.05%

35.85%

-25.80%

Volatility

SEIC vs. SMMT - Volatility Comparison

The current volatility for SEI Investments Company (SEIC) is 5.36%, while Summit Therapeutics Inc. (SMMT) has a volatility of 19.16%. This indicates that SEIC experiences smaller price fluctuations and is considered to be less risky than SMMT based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


SEICSMMTDifference

Volatility (1M)

Calculated over the trailing 1-month period

5.36%

19.16%

-13.80%

Volatility (6M)

Calculated over the trailing 6-month period

18.65%

56.82%

-38.17%

Volatility (1Y)

Calculated over the trailing 1-year period

22.40%

75.65%

-53.25%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

22.40%

185.23%

-162.83%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

25.68%

144.54%

-118.86%

Dividends

SEIC vs. SMMT - Dividend Comparison

SEIC's dividend yield for the trailing twelve months is around 1.15%, while SMMT has not paid dividends to shareholders.


PositionTTM20252024202320222021202020192018201720162015
SEIC
SEI Investments Company
1.15%1.23%1.15%1.40%1.42%1.26%1.25%1.04%1.36%0.81%1.09%0.95%
SMMT
Summit Therapeutics Inc.
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%

Financials

SEIC vs. SMMT - Financials Comparison

This section allows you to compare key financial metrics between SEI Investments Company and Summit Therapeutics Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.00100.00M200.00M300.00M400.00M500.00M600.00M20222023202420252026
622.18M
0
(SEIC) Total Revenue
(SMMT) Total Revenue
Values in USD except per share items

Frequently Asked Questions


SEIC and SMMT have a correlation of 0.18, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

SMMT has higher volatility (19.16%) compared to SEIC (5.36%). In terms of maximum drawdown, SEIC dropped -71.17% vs SMMT's -95.75%.

SEIC currently has the higher Sharpe Ratio (0.35 vs -0.40), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for SEIC and SMMT

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer